These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22226319)

  • 21. Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients.
    Voeten JT; Groen J; van Alphen D; Claas EC; de Groot R; Osterhaus AD; Rimmelzwaan GF
    J Clin Microbiol; 1998 Dec; 36(12):3527-31. PubMed ID: 9817867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of influenza A virus nucleoprotein antibody (IgM, IgA, and IgG) in serum and oral fluid specimens from pigs infected under experimental conditions.
    Panyasing Y; Goodell CK; Giménez-Lirola L; Kittawornrat A; Wang C; Schwartz KJ; Zimmerman JJ
    Vaccine; 2013 Dec; 31(52):6210-5. PubMed ID: 24200976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmablast-derived polyclonal antibody response after influenza vaccination.
    He XS; Sasaki S; Narvaez CF; Zhang C; Liu H; Woo JC; Kemble GW; Dekker CL; Davis MM; Greenberg HB
    J Immunol Methods; 2011 Feb; 365(1-2):67-75. PubMed ID: 21182843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.
    Downie JC
    J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody.
    Saito S; Sano K; Suzuki T; Ainai A; Taga Y; Ueno T; Tabata K; Saito K; Wada Y; Ohara Y; Takeyama H; Odagiri T; Kageyama T; Ogawa-Goto K; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    PLoS Pathog; 2019 Jan; 15(1):e1007427. PubMed ID: 30605488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkyl polyglycoside, a highly promising adjuvant in intranasal split influenza vaccines.
    Wu H; Bao Y; Wang X; Zhou D; Wu W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28129034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
    Murphy BR; Graham BS; Prince GA; Walsh EE; Chanock RM; Karzon DT; Wright PF
    J Clin Microbiol; 1986 Jun; 23(6):1009-14. PubMed ID: 3754878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
    Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
    Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
    Proudfoot O; Esparon S; Tang CK; Laurie K; Barr I; Pietersz G
    BMC Infect Dis; 2015 Feb; 15():101. PubMed ID: 25887952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum.
    Gorse GJ; Patel GB; Vitale JN; O'Connor TZ
    Clin Vaccine Immunol; 2010 Dec; 17(12):1875-80. PubMed ID: 20943876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic.
    Kumagai T; Nakayama T; Okuno Y; Kase T; Nishimura N; Ozaki T; Miyata A; Suzuki E; Okafuji T; Okafuji T; Ochiai H; Nagata N; Tsutsumi H; Okamatsu M; Sakoda Y; Kida H; Ihara T
    Viral Immunol; 2014 Oct; 27(8):368-74. PubMed ID: 25211638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition.
    Reuman PD; Bernstein DI; Keely SP; Sherwood JR; Young EC; Schiff GM
    Antiviral Res; 1990 Mar; 13(3):103-10. PubMed ID: 2353803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between antibody titers and protection against influenza virus infection within households.
    Tsang TK; Cauchemez S; Perera RA; Freeman G; Fang VJ; Ip DK; Leung GM; Malik Peiris JS; Cowling BJ
    J Infect Dis; 2014 Sep; 210(5):684-92. PubMed ID: 24676208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of the local secretory antibody to influenza A virus infection.
    Richman DD; Murphy BR; Tierney EL; Chanock RM
    J Immunol; 1974 Nov; 113(5):1654-6. PubMed ID: 4213978
    [No Abstract]   [Full Text] [Related]  

  • 37. Live, attenuated influenza A/England/42/72 (H3N2) virus vaccine: a field trial.
    Rubin RJ; Noble GR; Corey L; Brown WJ; Brandling-Bennett D; Kaye HS; Coleman MT; Gregg MB; Dowdle WR
    J Infect Dis; 1976 Jun; 133(6):613-20. PubMed ID: 778302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans.
    Brown TA; Murphy BR; Radl J; Haaijman JJ; Mestecky J
    J Clin Microbiol; 1985 Aug; 22(2):259-64. PubMed ID: 4031039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus.
    Suzuki T; Kawaguchi A; Ainai A; Tamura S; Ito R; Multihartina P; Setiawaty V; Pangesti KN; Odagiri T; Tashiro M; Hasegawa H
    Proc Natl Acad Sci U S A; 2015 Jun; 112(25):7809-14. PubMed ID: 26056267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.